Getein Biotech, Inc. Class A · SSE:603387

Getein Biotech, Inc. Class A shareholders

Getein Biotech, Inc. Class A on 6ix: holders from US fund reports. Largest: State Street(R) SPDR(R) Portfolio Emerging Markets ETF, Acadian Emerging Markets Portfolio and Emerging Markets Core Equity 2 Portfolio. Each with its filing.

Shareholders

HolderSharesValueChangeAs of
State Street(R) SPDR(R) Portfolio Emerging Markets ETF642KUS$715KNo changeJun 30, 2026
Acadian Emerging Markets Portfolio641KUS$845KNewJul 31, 2026
Emerging Markets Core Equity 2 Portfolio198KUS$261K−40,000Jul 31, 2026
State Street(R) SPDR(R) S&P(R) China ETF80,228US$89,352−3,200Jun 30, 2026
Dimensional Emerging Core Equity Market ETF52,900US$69,715+7,600Jul 31, 2026
The Emerging Markets Small Cap Series45,600US$60,108No changeJul 31, 2026
Dimensional Emerging Markets Value Fund36,800US$48,508NewJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF35,600US$46,916No changeJul 31, 2026
Dimensional Emerging Markets Value ETF33,800US$44,543No changeJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF31,000US$40,854No changeJul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF27,128US$30,213+2,000Jun 30, 2026
Emerging Markets Social Core Equity Portfolio16,600US$21,881NewJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio9,212US$12,143No changeJul 31, 2026
World ex U.S. Core Equity Portfolio8,036US$10,593No changeJul 31, 2026

Getein Biotech, Inc. Class A insider trades